Results 181 to 190 of about 51,246 (252)

Correction to: P2 purinergic receptors regulate the progression of colorectal cancer. [PDF]

Purinergic Signal
Zhang WJ, Zhang LP, Lin SJ, Wang CY, Le YG.   +4 more
europepmc   +1 more source

Purinergic Receptors Crosstalk with CCR5 to Amplify Ca²⁺ Signaling. [PDF]

Cell Mol Neurobiol, 2021
Horioka M, Ceraudo E, Lorenzen E, Sakmar TP, Huber T.   +4 more
europepmc   +1 more source

Linarine inhibits inflammatory responses in dry eye disease mice by modulating purinergic receptors. [PDF]

Front Immunol
Liu P, Jiang P, Tan K, Yu Y, Qin G, Liu T, Tian S, Peng J, Peng Q.   +8 more
europepmc   +1 more source

Receptor-specific Ca²⁺ oscillation patterns mediated by differential regulation of P2Y purinergic receptors in rat hepatocytes. [PDF]

iScience, 2021
Corrêa-Velloso JC, Bartlett PJ, Brumer R, Gaspers LD, Ulrich H, Thomas AP.   +5 more
europepmc   +1 more source

The functional role of P2 purinergic receptors in the progression of gastric cancer. [PDF]

Purinergic Signal
Zou FL, Liu JP, Zuo C, He PF, Ye JX, Zhang WJ.   +5 more
europepmc   +1 more source

Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue. [PDF]

Int Immunopharmacol, 2021
Leão Batista Simões J, Fornari Basso H, Cristine Kosvoski G, Gavioli J, Marafon F, Elias Assmann C, Barbosa Carvalho F, Dulce Bagatini M.   +7 more
europepmc   +1 more source

Purinergic P1 Receptor [PDF]

, 2020
openaire   +1 more source

P2 purinergic receptors regulate the progression of colorectal cancer. [PDF]

Purinergic Signal
Zhang WJ, Zhang LP, Lin SJ, Wang CY, Le YG.   +4 more
europepmc   +1 more source

Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome. [PDF]

Int J Mol Sci, 2021
Cano-Martínez A, Bautista-Pérez R, Castrejón-Téllez V, Carreón-Torres E, Pérez-Torres I, Díaz-Díaz E, Flores-Estrada J, Guarner-Lans V, Rubio-Ruíz ME.   +8 more
europepmc   +1 more source

A₃ Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma. [PDF]

Front Oncol, 2021
Vincenzi F, Rotondo JC, Pasquini S, Di Virgilio F, Varani K, Tognon M.   +5 more
europepmc   +1 more source